Our Company Our Values Our Executive Team Our Board of Directors Open Payments and Transparency At Ironwood, we are committed to finding new treatments for patients living with GI diseases Who is Ironwood? Our vision is clear: bring new, differentiated therapies to the millions of patients who live with GI diseases. Our in-market product, LINZESS® (linaclotide), discovered in-house, is the branded prescription market leader in its class. We believe we have what it takes to achieve our vision and we’re all in. Together, we’re paving a path to long-term success. I am excited about the opportunity to be GI-focused and to bring exciting new therapies to our trusted GI community.” Robin May, Clinical Sales Specialist, Jefferson City, MO Everyone at Ironwood is a true owner of the company. The ownership mindset extends beyond the home office and out into the field sales organization. Being an owner, I am interested in the entire company doing well, not just myself or my team.” Stacy Pokrywka, Regional Sales Manager, Great Lakes Our Values Our Executive Team Our Board of Directors Join Us When you join Ironwood, you join more than just a company. View Open Positions Our Company Our Values Our Executive Team Our Board of Directors Open Payments and Transparency Our Product Discovery of Linaclotide Report a possible side effect Our Pipeline Partnerships Patients Join Us Open Positions Internships, Co-ops and Fellowships Things You Should Know Investors Events & Presentations Corporate Governance Financial Information Stock Information Investor FAQ Press Releases Investor Contacts Media Contact Us Follow Us Privacy Policy Terms of Use California Privacy Policy Site Map Contact Us Copyright © 2021, Ironwood Pharmaceuticals, Inc. All Rights Reserved LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.